---
title: "OrganaBio: The Supply Brain | Jordan Greenberg"
description: Jordan Greenberg, Ph.D. has over 8 years of experience in the fields of stem cell research and tissue engineering using pluripotent stem cells and mesenchymal stem/stromal cells. Dr. Greenberg received his bachelor of science in Chemical Engineering from the University of Florida and his Ph.D. in Biomedical Engineering from the University of Miami.
---

[![OrganaBio-logo-rev-white-copy](https://blog.organabio.com/hs-fs/hubfs/OrganaBio-logo-rev-white-copy.png?width=979&height=239&name=OrganaBio-logo-rev-white-copy.png "OrganaBio-logo-rev-white-copy")](https://www.organabio.com)

![brain](https://blog.organabio.com/hubfs/marketing/brain.png "brain")

# The Supply Brain

Addressing supply chain challenges in cell and gene therapy.

The OrganaBio Blog

## Jordan Greenberg

![Jordan Greenberg](https://blog.organabio.com/hubfs/Imported%20images/Jordan.jpg)

Jordan Greenberg, Ph.D. has over 8 years of experience in the fields of stem cell research and tissue engineering using pluripotent stem cells and mesenchymal stem/stromal cells. Dr. Greenberg received his bachelor of science in Chemical Engineering from the University of Florida and his Ph.D. in Biomedical Engineering from the University of Miami.

### Recent Posts

## [Cell Therapy for COVID-19](https://blog.organabio.com/en/mscs/cell-therapy-for-covid-19)

 Posted by [Jordan Greenberg](https://blog.organabio.com/en/author/jordan) on August 03, 2020

- [Tweet](https://twitter.com/share)

In late 2019, cases of Coronavirus Disease 2019 (COVID-19) began to emerge out of Wuhan, China. Since then, the disease has proven to be highly contagious and has rapidly spread around the world, becoming a global pandemic. COVID-19 is caused by the Severe Acute Respiratory Distress Syndrome Conoravirus 2 (SARS-CoV-2). SARS-CoV-2 attacks host cells by the binding of its spike protein to the angiotensin I converting enzyme 2 (ACE2) receptor on cell membranes ([1](https://www.ncbi.nlm.nih.gov/pubmed/19198616)). ACE2 receptors are primarily found on lung alveolar type II cells and capillary endothelial cells in the lungs, which helps to explain the prevalence of respiratory distress associated with COVID-19 ([2](https://www.ncbi.nlm.nih.gov/pubmed/32257554)). In addition to the lungs, ACE2 receptors have also been identified in the heart, liver, kidney, and digestive organs which may help to explain why severe COVID-19 patients display myocardial injury, arrhythmia, acute kidney injury, shock, and death from multiple organ dysfunction/failure ([1](https://www.ncbi.nlm.nih.gov/pubmed/19198616)).

[Read More](https://blog.organabio.com/en/mscs/cell-therapy-for-covid-19)

 0 Comments **//** [View or add comments](https://blog.organabio.com/en/mscs/cell-therapy-for-covid-19#comments-listing)

 Topics: [Immune Cells](https://blog.organabio.com/en/tag/immune-cells), [Allogeneic Cell Therapy](https://blog.organabio.com/en/tag/allogeneic-cell-therapy), [covid-19](https://blog.organabio.com/en/tag/covid-19), [MSCs](https://blog.organabio.com/en/tag/mscs)

[All posts](https://blog.organabio.com/en/all)

Add a Comment

### Recent Posts

### Posts by Tag

- [Allogeneic Cell Therapy (7)](https://blog.organabio.com/en/tag/allogeneic-cell-therapy)
- [Immune Cells (4)](https://blog.organabio.com/en/tag/immune-cells)
- [MSCs (4)](https://blog.organabio.com/en/tag/mscs)
- [OrganaBio (3)](https://blog.organabio.com/en/tag/organabio)
- [covid-19 (3)](https://blog.organabio.com/en/tag/covid-19)
- [Hematopoietic Stem Cells (2)](https://blog.organabio.com/en/tag/hematopoietic-stem-cells)
- [B cells (1)](https://blog.organabio.com/en/tag/b-cells)
- [Exosomes (1)](https://blog.organabio.com/en/tag/exosomes)
- [Gene Editing (1)](https://blog.organabio.com/en/tag/gene-editing)
- [Immunotherapy (1)](https://blog.organabio.com/en/tag/immunotherapy)
- [NK cells (1)](https://blog.organabio.com/en/tag/nk-cells)
- [Starting Materials (1)](https://blog.organabio.com/en/tag/starting-materials-cell-gene-therapy)
- [T cells (1)](https://blog.organabio.com/en/tag/t-cells)
- [Uncategorized (1)](https://blog.organabio.com/en/tag/uncategorized)
- [cGMP Manufacturing (1)](https://blog.organabio.com/en/tag/cgmp-manufacturing-of-cell-and-gene-therapies)
- [donor variability (1)](https://blog.organabio.com/en/tag/donor-variability)
- [iPSCs (1)](https://blog.organabio.com/en/tag/ipscs)
- [immunomodulation (1)](https://blog.organabio.com/en/tag/immunomodulation)
- [mesenchymal stromal cells (1)](https://blog.organabio.com/en/tag/mesenchymal-stromal-cells)
- [supply chain (1)](https://blog.organabio.com/en/tag/supply-chain)

See all